SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-019521
Filing Date
2018-03-22
Accepted
2018-03-22 13:43:52
Documents
2
Period of Report
2018-03-20

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7961
2 EX-24 ex-24.htm EX-24 10471
  Complete submission text file 0001104659-18-019521.txt   19860
Mailing Address C/O ATLAS VENTURE 890 WINTER STREET WALTHAM MA 02451
Business Address
FORMELA JEAN FRANCOIS (Reporting) CIK: 0001030575 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 18706424

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences